Presented at the Keystone Symposia on Molecular and Cellular Biology, 2018 Microbiome, Host Resistance and Disease (X4)and 2018 Cancer Immunotherapy: Combinations (C5), in Banff, Canada.
Identification of novel intestinal microbiome-derived factors that modulate host innate immune responses
